Evidence map›Paper›PMID 41425113›Full record

ArticleClinical, cosmetic and investigational dermatology2025

Current Trends and Future Insights on Rosacea Treatment: A Bibliometric Analysis.

Dongxue Wang, Jinfang Zhang, Bin Wang, Jiefang Gao, Guoqiang Zhang

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dongxue WangDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, People's Republic of China.ORCID 0000-0002-0467-1464
Jinfang ZhangDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, People's Republic of China.
Bin WangDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, People's Republic of China.ORCID 0000-0002-4953-5239
Jiefang GaoDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, People's Republic of China.
Guoqiang ZhangDepartment of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050031, People's Republic of China.ORCID 0000-0002-4132-1690

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rosacea involves immune, neurovascular, and microbial factors, but its complex mechanisms are poorly understood, hindering effective treatment development. This study aims to examine research trends and significant contributions in the treatment of rosacea. Methods: Publications related to rosacea treatment were retrieved from the Web of Science Core Collection (WoSCC). Bibliometric analysis and visualization were performed using VOSviewer, CiteSpace, and the R package "bibliometrix". Results: By June 7, 2024, 1389 English-language publications published between 1970 and 2024 were identified for analysis. The leading research countries were the United States (446 articles) and China (149 articles), with the Central South University (95 articles) being the most productive institution. Key journals included Conclusion: This study underscores the dynamic landscape of research in rosacea treatment, synthesizes current areas of emphasis, and forecasts future trends. Future developments in rosacea research may concentrate on integrating precision medicine approaches by linking molecularly defined pathogenic mechanisms with standardized classification systems, thereby facilitating targeted and multidisciplinary treatment strategies.

Indexed as

bibliometric analysisimmune dysregulationquality of liferosaceatreatment

Identifiers

PMID41425113
PMCPMC12714495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.